On 4/4/25, Novavax Inc (NASDAQ: NVAX) stock enjoyed a major increase of 11.4%, closing at $6.24. Moreover, exceptionally high trading volume at 215% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months and has declined -14.0% during the last week.
Current PriceTarget Research Rating
Novavax is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment